| Ident. | Authors (with country if any) | Title |
|---|
| 000175 (2021) |
Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen Sliwa | SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications. |
| 000279 (2021) |
Osama A. Badary [Égypte] | Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs. |
| 000436 (2021) |
Rajnish Kumar [Inde] ; Anju Sharma [Inde] ; Janmejai Kumar Srivastava [Inde] ; Mohammed Haris Siddiqui [Inde] ; Md Sahab Uddin [Bangladesh] ; Lotfi Aleya [France] | Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications. |
| 000674 (2021) |
Hussain Ahmed Raza [Pakistan] ; Javeria Tariq [Pakistan] ; Vikas Agarwal [Inde] ; Latika Gupta [Inde] | COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases. |
| 000694 (2021) |
Samuel A. Berkman [États-Unis] ; Victor F. Tapson [États-Unis] | COVID-19 and Its Implications for Thrombosis and Anticoagulation. |
| 000766 (2021) |
Vakaramoko Diaby [États-Unis] ; Reem D. Almutairi [États-Unis] ; Ziyan Chen [États-Unis] ; Richard K. Moussa ; Abdrahmane Berthe [Canada] | A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19. |
| 000838 (2020) |
Seema Rani [Inde] ; Sandeep Grover [Inde] ; Aseem Mehra [Inde] ; Swapnajeet Sahoo [Inde] | Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients. |
| 000855 (2020) |
Dinesh Kaul [Inde] | An overview of coronaviruses including the SARS-2 coronavirus - Molecular biology, epidemiology and clinical implications. |
| 000952 (2020) |
Mario B. García-Saavedra ; Renzo R. Rosales-Gutiérrez [Pérou] ; Esmeralda Valverde [Pérou] ; Maryuri Chumbes-Aguirre [Pérou] ; Ricardo Alvarado [Pérou] ; Robert Polo [Pérou] ; Rubén Aza Ero [Pérou] ; Carlos Chávez [Pérou] | [Cardiovascular implications of SARS-CoV-2 infection: A literature review]. |
| 000981 (2020) |
Giulia Iannaccone [Italie] ; Roberto Scacciavillani [Italie] ; Marco Giuseppe Del Buono [Italie] ; Massimiliano Camilli [Italie] ; Claudio Ronco [Italie] ; Carl J. Lavie [États-Unis] ; Antonio Abbate [États-Unis] ; Filippo Crea [Italie] ; Massimo Massetti [Italie] ; Nadia Aspromonte [Italie] | Weathering the Cytokine Storm in COVID-19: Therapeutic Implications. |
| 000A10 (2020) |
Ohad Oren ; Eric H. Yang ; Ty J. Gluckman ; Erin D. Michos ; Roger S. Blumenthal ; Bernard J. Gersh | Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials. |
| 000B06 (2020) |
Rami A. Ballout [États-Unis] ; Dmitri Sviridov [Australie] ; Michael I. Bukrinsky [États-Unis] ; Alan T. Remaley [États-Unis] | The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications. |
| 000B46 (2020) |
Marco Tuccori [Italie] ; Irma Convertino [Italie] ; Sara Ferraro [Italie] ; Emiliano Cappello [Italie] ; Giulia Valdiserra [Italie] ; Daniele Focosi [Italie] ; Corrado Blandizzi [Italie] | The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance. |
| 000B78 (2020) |
Abdullahi Rabiu Abubakar [Nigeria] ; Ibrahim Haruna Sani [Nigeria] ; Brian Godman [Royaume-Uni] ; Santosh Kumar [Inde] ; Salequl Islam [Bangladesh] ; Iffat Jahan [Bangladesh] ; Mainul Haque [Malaisie] | Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications. |
| 000B81 (2020) |
Abdul Arif Khan [Inde] ; Zakir Khan [États-Unis] | System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation. |
| 000C61 (2020) |
Khalid M. Dousa [États-Unis] ; Sharad S. Malavade [États-Unis] ; Jennifer Furin [États-Unis] ; Barbara Gripshover [États-Unis] ; Marjorie Hatszegi [États-Unis] ; Leila Hojat [États-Unis] ; Elie Saade [États-Unis] ; Robert A. Salata [États-Unis] | SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis. |
| 000C68 (2020) |
Alexandre Carvalho [États-Unis] ; Rana Alqusairi [États-Unis] ; Anna Adams [États-Unis] ; Michelle Paul [États-Unis] ; Neelay Kothari [États-Unis] ; Stevany Peters [États-Unis] ; Anthony T. Debenedet [États-Unis] | SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease. |
| 000C86 (2020) |
Tessa R. Englund [États-Unis] ; Alan C. Kinlaw [États-Unis] ; Saira Z. Sheikh [États-Unis] | Rise and Fall: Hydroxychloroquine and COVID-19 Global Trends: Interest, Political Influence, and Potential Implications. |
| 000D14 (2020) |
Alexis Mathian [France] ; Zahir Amoura [France] | Response to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin et al. |
| 000D70 (2020) |
Israel Abebrese Sefah [Ghana] ; Olayinka O. Ogunleye [Nigeria] ; Darius Obeng Essah [Ghana] ; Sylvia A. Opanga [Kenya] ; Nadia Butt [Kenya] ; Annie Wamaitha [Kenya] ; Anastasia Nkatha Guantai [Kenya] ; Ibrahim Chikowe [Malawi] ; Felix Khuluza [Malawi] ; Dan Kibuule [Namibie] ; Lahya Nambahu [Namibie] ; Abdullahi Rabiu Abubakar [Nigeria] ; Ibrahim Haruna Sani [Nigeria] ; Zikria Saleem [Pakistan] ; Aubrey C. Kalungia [Zambie] ; Thuy Nguyen Thi Phuong [Viêt Nam] ; Mainul Haque [Malaisie] ; Salequl Islam [Bangladesh] ; Santosh Kumar [Inde] ; Jacqueline Sneddon [Royaume-Uni] ; Joshua Wamboga [Ouganda] ; Janney Wale [Australie] ; Nenad Miljkovi [Serbie] ; Amanj Kurdi [Royaume-Uni, Iraq] ; Antony P. Martin [Royaume-Uni] ; Brian Godman [Royaume-Uni, Afrique du Sud, Malaisie, Suède] | Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. |
| 000D71 (2020) |
Brian Godman [Royaume-Uni, Suède, Afrique du Sud, Malaisie] ; Mainul Haque [Malaisie] ; Salequl Islam [Bangladesh] ; Samiul Iqbal [Bangladesh] ; Umme Laila Urmi [Bangladesh] ; Zubair Mahmood Kamal [États-Unis] ; Shahriar Ahmed Shuvo [Bangladesh] ; Aminur Rahman [Bangladesh] ; Mustafa Kamal [Bangladesh] ; Monami Haque [Bangladesh] ; Iffat Jahan [Bangladesh] ; Md Zakirul Islam [Bangladesh] ; Mohammad Monir Hossain [Bangladesh] ; Munzur-E-Murshid [Bangladesh] ; Santosh Kumar [Inde] ; Jaykaran Charan [Inde] ; Rohan Bhatt [Inde] ; Siddhartha Dutta [Inde] ; Jha Pallavi Abhayanand [Inde] ; Yesh Sharma [Inde] ; Zikria Saleem [Pakistan] ; Thuy Nguyen Thi Phuong [Viêt Nam] ; Hye-Young Kwon [Royaume-Uni, Corée du Sud] ; Amanj Kurdi [Royaume-Uni, Iraq] ; Janney Wale [Australie] ; Israel Sefah [Ghana] | Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future. |
